Invited Lectures

1988: University of Copenhagen, The Panum Institute, Copenhagen, Denmark. Seminar Title: Zonation of Hepatic Lipogenic Enzymes as Identified by Dual-Digitonin-Pulse Perfusion.

1988: Medical College of Pennsylvania, Philadelphia, PA. Seminar Title: Insulin Stimulates the Dephosphorylation and Activation of Acetyl-CoA Carboxylase.

1991: New York Lipid Club (NYLC), New York, NY. Seminar Title: Novel Insights into the Regulation of Acetyl-CoA Carboxylase.

1997: University of California, Davis, CA. Seminar Title: Novel Pharmacological Approaches for the Treatment of Obesity, Insulin Resistance, and NIDDM.

1997: IBC Conference on Signal Transduction Therapy, San Diego, CA. Seminar Title: Enhancement of Insulin Signaling via Inhibition of Insulin Receptor Tyrosine Phosphatase Activity.

1998: Bi-Monthly Meeting of the Society of Cosmetic Chemists, Santa Ana, CA. Seminar Title: Skin Care Issues for the Diabetic Patient.

1998: City of Hope Diabetes Research Center, Duarte, CA. Seminar Title: Inhibition of Phosphotyrosine Phosphatase Activity as a Novel Approach for the Treatment of Type 2 Diabetes.

1998: IBC Conference on The Management of Obesity and NIDDM, The Royal Society, London, UK. Seminar Title: Inhibitors of Insulin Receptor Tyrosine Phosphatase Activity.

1998: Northern California American Diabetes Association Research Symposium, San Francisco, CA. Seminar Title: Novel Pharmacological Approaches for Treating Type 2 Diabetes: Modulation of Insulin Signal Transduction.

1999: National Nutritional Foods Association (NNFA) Annual Exhibition, Santa Rosa, CA. Seminar Title: Nutraceutical Treatments Available for Type 2 Diabetes.

1999: University of California, Davis, CA. Seminar Title: Dietary Supplements: Much Ado About Nothing?

1999: American Academy of Anti-Aging Medicine Scientific Congress, Las Vegas, NE. Seminar Title: α-Lipoic Acid for Diabetes and Aging.

2002: Plexxikon Corporation, Berekely, CA. Seminar Title: Emerging Pharmacological Targets for the Treatment of Type 2 Diabetes.

2002: Northern California American Diabetes Association Research Symposium, San Francisco, CA. Seminar Title: Emerging Pharmacological Targets for the Treatment of Type 2 Diabetes.

2002: 2nd Inverness Symposium, Inverness, CA. Seminar Title: Does Oxidative Stress Play a Role in Insulin Resistance and β-cell Dysfunction?

2002: Shaklee Corporation, Pleasanton, CA. Seminar Title: Lipoic Acid: A Multi-Functional Antioxidant that Increases Insulin Sensitivity.

2002: University of California San Francisco Diabetes Center. Seminar Title: Oxidative Stress Activated Signaling Pathways: Mediators of Insulin Resistance, β-cell Dysfunction, and Diabetic Complications?

2003: University of California San Francisco School of Medicine. Department of Continuing Medical Education. Seminar Title: Antioxidants and Diabetes Mellitus.

2003: Quebec Association of Endocrinologists, Montreal, Canada. Symposium on Type 2 Diabetes. Seminar Title: Oxidative Stress and Stress-Activated Signaling Pathways - A Unifying Hypothesis of Type 2 Diabetes.

2004: Annual Meeting of the American Diabetes Association. Seminar Title: Lipoic Acid: A Multi-Functional Antioxidant that Increases Insulin Sensitivity.

2004: Russel Berrie International Diabetes Symposium, Jerusalem, Israel. Seminar Title: Lipoic Acid: An Oxidative Stress Antagonist to Combat Insulin Resistance and Inflammation.

2005: Mills-Peninsula Diabetes Research Institute. Seminar Title: The Role of Antioxidants and Vitamins in Diabetes.

2005: University of Southern Mississippi. Seminar Title: Oxidative Stress, Antioxidants, and Diabetes.